During the past decade, Ephrata Community Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 21 clinical trials were completed, i.e. on average, 47.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 20 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ephrata Community Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ephrata Community Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ephrata Community Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Invasive Breast Carcinoma" (4 trials) and "Stage IVA Lung Cancer AJCC v8" (4 trials). Many other conditions were trialed in "Ephrata Community Hospital" in a lesser frequency.

Most popular intervention types in "Ephrata Community Hospital" are "Drug" (46 trials), "Other" (41 trials), "Biological" (26 trials), "Procedure" (16 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (15 trials), "Biospecimen Collection" (10 trials), "Computed Tomography" (10 trials) and "Nivolumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Ephrata Community Hospital" are 50 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Ephrata Community Hospital". undefined are not yet recruiting, 10 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ephrata Community Hospital, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ephrata Community Hospital, 1 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Ephrata Community Hospital has several departments that took part in Clinical trials: "Ephrata Cancer Center" - 110 trials